Chairman of the Investment Committee at NLC Health Ventures
Check size: NLC publishes venture and fund participation routes but not one standard direct-investment check-size range.
Peter Veldman is listed in a Chairman of the Investment Committee capacity at NLC Health Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Explain the invention, unmet need, evidence, IP, regulatory path, team needs and why NLC's venture-building model is useful.
Validated inventions addressing unmet healthcare needs with strong clinical relevance, protectable technology and scalable commercial potential.
Innovations without a clear healthcare need, feasible development path or meaningful patient impact are less aligned.